ARCTURUS THERAPEUTICS HOLDINGS INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$65.78 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-03
- ARCTURUS THERAPEUTICS HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$65.78M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$80.94M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$27.89M, a 362.03% decline from fiscal 2022.
- ARCTURUS THERAPEUTICS HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $10.64M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$65.78M 10-K · filed 2026-03-03 | |
| 2024-12-31 | -$80.94M 10-K · filed 2026-03-03 | $81.05M 10-K · filed 2025-03-06 |
| 2023-12-31 | -$27.89M 10-K · filed 2026-03-03 | |
| 2022-12-31 | $10.64M 10-K · filed 2025-03-06 | |
| 2021-12-31 | -$203.67M 10-K · filed 2024-03-14 | |
| 2020-12-31 | -$72.15M 10-K · filed 2022-03-01 | |
| 2019-12-31 | -$25.92M 10-K · filed 2022-03-01 | |
| 2018-12-31 | -$21.60M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |